Is Surgery Partners Inc (SGRY) Stock a Good Buy for Short-term Investors?

Ulysses Smith

At the time of writing, Surgery Partners Inc [SGRY] stock is trading at $20.93, up 5.76%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SGRY shares have gain 2.65% over the last week, with a monthly amount drifted -3.10%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

On December 16, 2024, BofA Securities initiated with a Buy rating and assigned a price target of $30 on the stock. UBS started tracking the stock assigning a Buy rating and suggested a price target of $38 on October 14, 2024. KeyBanc Capital Markets initiated its recommendation with a Sector Weight. Macquarie started tracking with a Outperform rating for this stock on June 28, 2024, and assigned it a price target of $31. In a note dated March 06, 2024, Barclays initiated an Equal Weight rating and provided a target price of $35 on this stock.

For the past year, the stock price of Surgery Partners Inc fluctuated between $18.87 and $33.37. Currently, Wall Street analysts expect the stock to reach $40.8 within the next 12 months. Surgery Partners Inc [NASDAQ: SGRY] shares were valued at $20.93 at the most recent close of the market. An investor can expect a potential return of 94.94% based on the average SGRY price forecast.

Analyzing the SGRY fundamentals

According to Surgery Partners Inc [NASDAQ:SGRY], the company’s sales were 3.24B for trailing twelve months, which represents an 8.41% jump. Gross Profit Margin for this corporation currently stands at 0.24% with Operating Profit Margin at 0.11%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.1 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.22.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

It is important to note that Surgery Partners Inc [NASDAQ:SGRY] has a current ratio of 1.93. Further, the Quick Ratio stands at 1.78, while the Cash Ratio is 0.44. Considering the valuation of this stock, the price to sales ratio is 0.83, the price to book ratio is 1.53.

Transactions by insiders

Recent insider trading involved Wayne DeVeydt, former director, that happened on Oct 14 ’25 when 25000.0 shares were purchased. former director, Wayne DeVeydt completed a deal on Oct 09 ’25 to buy 3145.0 shares. Meanwhile, former director Wayne DeVeydt bought 25000.0 shares on Oct 08 ’25.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.